Styrax Life Sciences
India Updated 9 July 2026
Styrax Life Sciences is an API manufacturer based in India. It holds one active US drug master file. Customs aggregates show $1.1M of exports covering 13 molecules to 4 destinations in 2025.
1
registered plants
1 with an FDA FEI number
0
filings
across 0 regulators
These figures were checked against the regulators' own files on 25 July 2026
Sources: FDA Establishment Registration, read 4 May 2026.
Registered plants
| Site | FDA FEI |
| Anakapalli, India | 3018393466 |
What they file, and where
Also appears on these molecule pages
Scale
| Year | Revenue | Exports | Destinations |
| 2026 YTD | Not reported | $229K | 3 |
| 2025 | Not reported | $1.1M | 4 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Comparing suppliers?
Choose your molecules and target markets. Styrax Life Sciences comes back tiered against every other
supplier able to file there.
Start for free No sales call.
Sources on this page
- FDA
- Drug master files, establishment registration, inspection classifications
- EDQM
- Certificates of suitability
- Customs aggregates
- Export values, molecule and destination counts